Global Developments, Inc., (OTCMKTS:GDVM) is making an explosive move north as things heat up behind the scenes, which certainly gives the impression that the company is planning something here, like a reverse merger of an existing business in the company. GDVN is working to update its documents and there was only a reduction of 515 million shares as the shares issued to OMID were returned to the Treasury and cancelled. GDVM is the perfect merger candidate; the company a clean balance sheet with only $36,000 in total liabilities. On Monday alone, GDVM was up 40% on $440,000 in volume, suggesting something is afoot here.

Reverse merger stocks can be more explosive than biotechnology stocks when the incoming company has real value but is not discovered by investors and we have covered many on the website that have gone from pennies to dollars . Two recent RM runners that stand out are TSNP which has gone from pennies (where we first wrote about it) to several dollars per share. The other is HRBR which has gone from pennies (where we first talked about it) to $3+. Although nothing official has been announced yet, there is a lot going on behind the scenes here and some large small cap players are currently accumulating GDVM.

Global Developments, Inc., (OTCMKTS: GDVM) a Delaware corporation was incorporated in Delaware on December 9, 2004 as Autobahn International, Inc., changed its name to Global Developments Inc. on May 30, 2016, and changed its name to Global Developments Holdings, Inc. on September 20, 2018. The Company sought to focus on equity and debt financing opportunities and business acquisitions. The Company has not had any significant transactions since 2012. The business purpose of the Company is to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or business combination. similar companies with one or more target companies. The Company has not identified or selected any business combination. As of March 31, 2022, the Company has no significant activity. 36,000 liabilities.

To find out inside Scoop on GDVM Subscribe to Microcapdaily.com now by entering your email in the box below

GDVM

The Company is authorized to issue (i) 6,000,000,000 common shares, with a par value of $0.0000001 per share, of which 4,114,387,836 shares are issued and outstanding (and of which no shares are reserved for issuance under securities exercisable or exchangeable for, or convertible into, common stock), and (ii) 200,000,000 preferred shares, with a par value of $0.0000001 per share, none of which was issued and in circulation. The Company did not issue any share capital for the period ended March 31, 2022.

The majority shareholder of the Company holds 3,150,000,000 common shares of the Company, representing 76.56% of all issued and outstanding common shares. The majority shareholder has agreed to lend the Company up to an aggregate of $50,000 through the issuance of an unsecured promissory note to cover the Company’s expenses. The loan is repayable on demand. As of March 31, 2022, the Company had recorded $27,269 in notes payable between related parties, which relate to transfer agent fees, accounting services, state franchise fees and OTC market fees.

To learn more about GDVM, subscribe now!

Currently trading at a market valuation of $16 million GDVM just downgraded the OS by 525 million shares, leaving 3,589,387,836 shares outstanding. The majority shareholder of the company owns 3,150,000,000 shares, meaning it is very tightly held with only 324,744,968 unrestricted shares and a small free float. Although nothing official has been announced yet, there is a lot going on behind the scenes here and some large small cap players are currently hoarding GDVM here with an eye on a possible reverse merger. On Monday alone, GDVM was up 40% on $440,000 in volume, suggesting something is afoot here. We’ll update on GDVN when more details emerge, so make sure you’re subscribed to Microcapdaily.

Disclosure: We do not hold any long or short positions in GDVM and we have not been compensated for this article.

About The Author

Related Posts